Thursday July 28, 2022, 6 – 7 p.m. AET
Zoom link: https://monash.zoom.us/j/88641812944
Prof. Stephen Nicholls: RNA therapeutics that target LDL/PCSK
Professor Steve Nicholls is the inaugural Director of the Victorian Heart Institute and a Professor of Cardiology at Monash University. He is the Director at MonashHeart and will be the inaugural Director of the Victorian Heart Hospital when it opens in late 2022. Steve is a preventive cardiologist. His clinical interest is focused on identifying those at risk of heart disease earlier, and more effectively, and preventing catastrophic cardiovascular events from occurring. He is committed to solutions which improve equity across risk and management, focusing on women’s heart health and other under-served populations.
His work spans the translational spectrum from the lab bench to the bedside, with a focus on understanding the factors that promote plaque formation, novel vascular imaging and leadership of large-scale clinical trials of new therapies designed to reduce the risk of heart disease. He is Chair of the Australian Atherosclerosis Society Clinical Council, Australia and New Zealand Alliance for Cardiovascular Trials, Asia Pacific Cardiometabolic Consortium, President Elect of the Cardiac Society of Australia and New Zealand and a Fellow of the Australian Academy of Health and Medical Sciences.
Supported by our Atherosclerosis Education Program Partners
July 19 2022